The stock market has been off to a hot start so far in 2023. All four major U.S. stock indices are higher so far on the year, while the Nasdaq’s 15.75% return is more than double the next-best performer (the S&P 500). Still, there are some stocks that are losing steam and risk underperforming in
Stocks to sell
As our trusty authors have covered in detail, electric vehicle (EV) manufacturer Mullen Automotive (NASDAQ:MULN) just received what looks like a $110 million bailout. However, it’s an awfully flimsy lifeline for an automaker that’s in deep financial trouble. If you’re waiting around for MULN stock to recover, don’t hold your breath. It’s entirely possible that
Mullen Automotive (NASDAQ:MULN) has made news in recent weeks, but there’s one relatively small development that could have a much larger impact on MULN stock than you’d think at first glance. Last month, Mullen sued an online tech publication, seeking damages related to statements made in an article from this publication, regarding the settlement of
Don’t be fooled by high-yielding dividend stocks. Often, dividends are used to mask problems at a company in the same way that air fresheners are used to cover up putrid smells. Shareholders force poor performing companies, whose stock is tanking, to provide a high yielding dividend to attract and keep them. Without it, the share
Companies in getting sued by customers are the dividend stocks to avoid. Shareholders who sue the company are less serious. In either case, they are still an unnecessary distraction that might cause management to lose focus. When the three-month treasury yield is 5.096%, investors could buy risk-free government debt instead of dividend-paying companies with legal
There are plenty of risky dividend-paying stocks with company-specific issues that make them clearly dividend stocks to avoid, but there are also some names in this category where the reason to stay away is not so apparent. One such example is with shares in companies facing possible regulatory scrutiny. This regulatory scrutiny may threaten future
Penny stocks are enticing as they offer prospects of multibagger returns. High degree of speculation across penny stocks is another reason that makes it attractive for investors. Big trading gains are a possibility at the blink of an eye. However, amidst the ocean of names, there are penny stocks to avoid as they can continue
Dividend stocks tend to be a strong equity subclass for investment in general. Most stocks that pay dividends tend to be stable because consistently returning earnings to shareholders is not always possible in weaker companies. That includes the companies listed as some of the top dividend stocks to avoid. Over time a healthy payout range between
While it’s always important to conduct your own due diligence in the equities arena, there’s great value in understanding which hedge fund stocks to avoid. Put another way, these are the stocks that hedge funds are unloading, which should inspire additional research. Fundamentally, if the enterprises with the greatest access to information don’t believe in
Plenty of traders are still willing to risk their hard-earned capital on electric vehicle (EV) manufacturer Lucid Group (NASDAQ:LCID). I wish I could offer them some comfort and a positive outlook. However, LCID stock investors need to prepare for a crash landing. Lucid Group’s recently released results only add to the bearish thesis, unfortunately. Lucid Group’s
There’s a “good news, bad news” situation with global movie-theater chain AMC Entertainment (NYSE:AMC). The good news is that AMC Entertainment recently reported a heavy influx of moviegoers. On the other hand, the company’s financial situation is far from ideal, and AMC Entertainment is working hard to increase the number of AMC stock shares. AMC
EV stocks have been the subject of investment-related conversation for years. With Tesla (NASDAQ:TSLA) constantly commanding headlines over the past five years, you’d have to live under a rock to have missed the growing EV trend. The push toward net zero is intensifying, and most agree that electric cars will be part of that transition. Governments worldwide
Investors have been turning to companies with high dividend yields to manage current market volatility. A steady income stream provides a nice ballast for a portfolio during uncertain times. But not all such companies are created equal. These three dividend stocks to sell will not give investors the security they are hoping for. When looking at dividend-paying
There are winners and losers in every type of market. While the share prices of some companies soar, others plunge. This can be due to a number of factors, ranging from earnings misses and weak forward guidance to fraud, mismanagement, bankruptcy and public criticism. Whatever the reason, there are many stocks that investors should avoid
Throughout the pandemic, EV stocks soared on the belief that a paradigm shift was underway in the automotive space. Though that continues to hold true, it’s apt at this time to contemplate which EV stocks might be ripe for selling. A myriad of headwinds, including the economic slowdown, supply-chain constraints, and the dwindling geo-political situation, was
The markets may be showing solid signs of improvement, but there are still many stocks to sell. In fact, in this environment of elevated interest rates, stocks with unrealistically high valuations are likely to come back to earth sooner rather than later. So, here are seven stocks to sell in April that are very likely to
As the tech market starts to come back, investors are on the lookout for dividend stocks to sell to keep their porfolios clean. Whether for passive income or building generational wealth, everyone likes a dividend.Stocks with high dividends have kind of been neglected in the tech-mania that’s been taking over the stock market. But not
Finding the best pharma stocks to sell can be an all-or-nothing kind of business. If you score on a company making a breakthrough in a new drug or treatment, the rewards can be extreme, but investing in pharma stocks can also mean heavy expenditures on research and testing for a drug that may not perform
If Novavax (NASDAQ:NVAX) stock investors are looking for a shot in the arm, they’re going to be disappointed. Even Novavax’s management expressed doubts regarding the company’s ability to continue long term. Like it or not, the evidence overwhelmingly suggests that it’s not a wise move to take a share position in Novavax. Let’s face it. Covid-19
Among cannabis stocks, SNDL (NASDAQ:SNDL) has been one that screens well as a value play. Even though this Canada-based integrated cannabis company isn’t cheap on a price-to-earnings basis, SNDL stock has for quite some time traded at a discount to its tangible book value. But investors who have bought it based on its low valuation